Bal Pharma Limited has informed the Exchange regarding Change in Director(s) of the company.
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma Limited has informed the stock exchanges that Mr. H.S. Venkatesh (DIN: 01776040), an Independent Director, has completed his second term and ceased to be on the Board effective September 30, 2025. As a result, he also stepped down as Chairman/Member of the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee. The company has disclosed this change under SEBI's Listing Regulations. No replacement appointment was announced in this filing.
This is a routine, planned end of tenure for an independent director and not a sudden exit. Shareholders should watch for a replacement independent director appointment in the coming weeks, as the company will need to maintain the required board composition and committee quorum under SEBI norms.